AUPH vs BAC Stock Comparison

AUPH currently leads BAC in this stock comparison, with AIQ scores of 75 vs 58. The clearest difference is momentum, while BAC has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 17 points
AUPH
Healthcare
vs
BAC
Financial Services
AUPH
Aurinia Pharmaceuticals Inc.
Leads
Price
$15.73
Day move
-2.96%
AIQ Score
75/100
Best edge
Momentum
Sector
Healthcare
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between AUPH and BAC?

AUPH leads the current stock comparison as Aurinia Pharmaceuticals Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Aurinia Pharmaceuticals Inc. vs Bank of America Corporation

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 65/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 8/10

AUPH leads

AUPH leads by 17 AIQ points, primarily on Momentum and Value, and the lead has widened from 11 points over 30 sessions. Wall Street currently favors BAC on target upside.

Stable: 4 of 6 evidence groups support AUPH, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
AUPH

Aurinia Pharmaceuticals Inc.

Leads
AIQ Score
75/100
AIQ Edge Score
10/10
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors AUPH over BAC, 75 versus 58 as of Nov 15, 2026. AUPH's advantage is driven primarily by stronger momentum and value, while BAC holds the stronger risk resilience profile. AUPH also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BAC. 4 of 6 covered evidence groups favor AUPH today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. AUPH lead: Strengthening — the AIQ differential moved from 11 to 17 points over 30 sessions.

Compare Aurinia Pharmaceuticals Inc. and Bank of America Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AUPH
-46.1%
BAC
+24.0%

Total return comparison

Growth of $10,000, distributions reinvested

AUPH $5,387 · BAC $12,399

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AUPH and BAC against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AUPH advantage
0
BAC advantage
  • Momentum73 vs 37
    AUPH +36
  • Value84 vs 68
    AUPH +16
  • Risk Resilience68 vs 83
    BAC +15
  • Quality77 vs 64
    AUPH +13

4 of 6 evidence groups favor AUPH. AUPH’s edge is concentrated in momentum and value; BAC keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

AUPH0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon
  • BB Lower Band Breach — bullish, volatility, short horizon
BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)

AUPH's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — AUPH and BAC both carry a full feed there.

The central trade-off

AUPH (Aurinia Pharmaceuticals Inc.): the stronger current systematic profile, led by momentum and value.

BAC (Bank of America Corporation): the counter-case, on risk resilience, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AUPH

AUPH on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AUPH

AUPH on combined revenue and EPS growth.

Value

AUPH

AUPH on the peer-relative Value factor, by 16 points.

Momentum

AUPH

AUPH on the Momentum factor, by 36 points.

Lower downside

BAC

BAC on Risk Resilience, by 15 points.

Analyst upside

BAC

BAC on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors AUPH, analyst targets favor BAC. That disagreement is the most useful thing on this page.

MeasureAUPHBACNote
Implied upside to target+14.4%+24.1%BAC has more room
Target dispersion0%+25.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering725Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor AUPH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreAUPH75 vs 58
FundamentalsAUPHEPS growth -17.2% vs -23.8%; TTM ROE 4.8% vs 2.3%; gross margin 90.7% vs 60.4%; operating margin 48.6% vs 22.4%
ValuationAUPHValue 84 vs 68
TechnicalsAUPHPrice vs 50-day -4.6% vs -5.6%; vs 200-day 0% vs -7%
Risk ResilienceBACRisk Resilience 68 vs 83
Analyst expectationsBACTarget upside 14.4% vs 24.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AUPH and BAC and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 17 points. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AUPH.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

AUPH lead: Strengthening — the AIQ differential moved from 11 to 17 points over 30 sessions.

May 27AUPH leads above the line · BAC leads belowNov 13
Today
AUPH +17
75 vs 58
7 sessions ago
AUPH +18
76 vs 58
30 sessions ago
AUPH +11
73 vs 62
90 sessions ago
BAC +3
68 vs 71

The lead changed hands 3 times in this window, most recently on Aug 27 when AUPH moved ahead of BAC.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AUPHConflicted

2 bullish / 2 bearish, conflicted

Only AUPH

  • Golden Cross Active — bullish, trend, long horizon (4.77%)
  • Price Lost 200-Day MA — bearish, trend, long horizon
  • BB Lower Band Breach — bullish, volatility, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)

AUPH leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AUPHNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.96%, AIQ 0 points).

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Momentum gap — currently 36 points behind, the largest single contributor to AUPH's edge.
  2. 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3AUPH's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AUPH leads on balance
MetricAUPHBAC
Revenue growth (YoY)0.6%-3.3%
EPS growth (YoY)-17.2%-23.8%
Gross margin90.7%60.4%
Operating margin48.6%22.4%
Return on equity (TTM)4.8%2.3%
Debt to equity0.091.28

Performance

AUPH leads 4 of 6 windows
MetricAUPHBAC
1 week (5 sessions)-4.4%3.2%
1 month (20 sessions)-4.7%-0.4%
3 months (63 sessions)2.9%-20.1%
6 months (126 sessions)2.9%2.5%
Year to date-1.4%-7.2%
1 year (252 sessions)1.2%-5.7%

Technicals

AUPH has the stronger structure
MetricAUPHBAC
RSI (14)39.945.9
ADX (14)17.327.2
Price vs 50-day-4.6%-5.6%
Price vs 200-day0%-7%
Volatility (1M, annualized)36.7%24.8%

Risk

BAC is the more resilient
MetricAUPHBAC
Beta0.640.79
Sharpe ratio0.16-0.22
Sortino ratio0.23-0.29
Max drawdown-21.8%-23.7%
Current drawdown-15.5%-21.3%
Annualized volatility35.5%22.4%
Value at risk (95%)-3.4%-2.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AUPH or BAC?

On the Algovestiq AIQ Score, AUPH is the stronger of the two as of Nov 15, 2026, scoring 75 against BAC's 58. The edge comes from momentum and value. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AUPH or BAC the better buy right now?

AUPH carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor AUPH over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. AUPH leads Momentum by 36 points; AUPH leads Value by 16 points; BAC leads Risk Resilience by 15 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AUPH or BAC?

Analyst price targets imply +14.4% upside for AUPH and +24.1% for BAC, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors AUPH. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AUPH or BAC?

AUPH is the better-valued of the two on the peer-relative Value factor. AUPH on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AUPH or BAC?

AUPH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AUPH or BAC?

AUPH on the Momentum factor, by 36 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AUPH or BAC?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 15 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AUPH more profitable than BAC?

AUPH leads on the comparable margin measures — gross margin 90.7% vs 60.4%; operating margin 48.6% vs 22.4%; ttm roe 4.8% vs 2.3%.

Is AUPH's lead over BAC getting stronger or weaker?

AUPH lead: Strengthening — the AIQ differential moved from 11 to 17 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-08-27, when AUPH moved ahead of BAC.

What would change the AUPH vs BAC verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 36 points behind, the largest single contributor to AUPH's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; AUPH's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AUPH and BAC?

AUPH: 2 bullish / 2 bearish, conflicted. BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AUPH is Golden Cross Active (bullish, long horizon). On BAC it is Death Cross Active (bearish, long horizon).

Compare AUPH and BAC with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.